Increased expression of IL‐17A and limited involvement of IL‐23 in patients with palmo‐plantar (PP) pustular psoriasis or PP pustulosis; results from a randomised controlled trial

Palmo‐plantar pustular psoriasis (PPPP) and palmo‐plantar pustulosis (PPP) are chronic skin diseases with significant impact on quality of life.

[1]  A. Gottlieb,et al.  Investigator-initiated, open-label trial of ustekinumab for the treatment of moderate-to-severe palmoplantar psoriasis , 2013, The Journal of dermatological treatment.

[2]  A. Zbrozek,et al.  The Validity and Reproducibility of a Work Productivity and Activity Impairment Instrument , 1993, PharmacoEconomics.

[3]  A. Ishida-Yamamoto,et al.  Patients with palmoplantar pustulosis have increased IL‐17 and IL‐22 levels both in the lesion and serum , 2011, Experimental dermatology.

[4]  M. Rosenbach,et al.  Treatment of refractory tumor necrosis factor inhibitor-induced palmoplantar pustulosis: a report of 2 cases. , 2011, Archives of dermatology.

[5]  V. Sharma,et al.  Comparison of clobetasol propionate cream plus coal tar vs. topical psoralen and solar ultraviolet A therapy in palmoplantar psoriasis , 2011, Clinical and experimental dermatology.

[6]  A. Bruce,et al.  Mast Cells and Neutrophils Release IL-17 through Extracellular Trap Formation in Psoriasis , 2011, The Journal of Immunology.

[7]  P. C. van de Kerkhof,et al.  Management of palmoplantar pustulosis: do we need to change? , 2011, The British journal of dermatology.

[8]  P. Teeling,et al.  Overrepresentation of IL-17A and IL-22 Producing CD8 T Cells in Lesional Skin Suggests Their Involvement in the Pathogenesis of Psoriasis , 2010, PloS one.

[9]  U. Mrowietz,et al.  Ustekinumab in the treatment of palmoplantar pustulosis , 2010, The British journal of dermatology.

[10]  H. Hedstrand,et al.  Novel findings of Langerhans cells and interleukin‐17 expression in relation to the acrosyringium and pustule in palmoplantar pustulosis , 2010, The British journal of dermatology.

[11]  A. Blauvelt,et al.  Increased IL-23 expression in palmoplantar psoriasis and hyperkeratotic hand dermatitis. , 2010, Archives of dermatology.

[12]  A. Ishida-Yamamoto,et al.  Acrosyringium is the main site of the vesicle/pustule formation in palmoplantar pustulosis. , 2010, Journal of Investigative Dermatology.

[13]  C. Massone,et al.  Can we really separate palmoplantar pustulosis from psoriasis? , 2010, Journal of the European Academy of Dermatology and Venereology : JEADV.

[14]  R. Sabatini,et al.  IL-17 in Sera from Patients with Aggressive Periodontitis , 2010, Journal of dental research.

[15]  A. Menter,et al.  Palmoplantar psoriasis: a phenotypical and clinical review with introduction of a new quality-of-life assessment tool. , 2009, Journal of the American Academy of Dermatology.

[16]  J. Carucci,et al.  Low Expression of the IL-23/Th17 Pathway in Atopic Dermatitis Compared to Psoriasis1 , 2008, The Journal of Immunology.

[17]  Lisa C. Zaba,et al.  Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses , 2008, The Journal of Experimental Medicine.

[18]  J. Bazex,et al.  Palmoplantar pustulosis should not be considered as a variant of psoriasis , 2008, Journal of the European Academy of Dermatology and Venereology : JEADV.

[19]  Lisa C. Zaba,et al.  Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses , 2007, The Journal of experimental medicine.

[20]  S. Kõks,et al.  Association analysis of IL19, IL20 and IL24 genes in palmoplantar pustulosis , 2007, The British journal of dermatology.

[21]  Y. Konttinen,et al.  MMPs, IL-1, and TNF are Regulated by IL-17 in Periodontitis , 2007, Journal of dental research.

[22]  J. Leonardi-Bee,et al.  Interventions for chronic palmoplantar pustulosis. , 2006, The Cochrane database of systematic reviews.

[23]  M. Dhodapkar,et al.  Increased Expression of Interleukin 23 p19 and p40 in Lesional Skin of Patients with Psoriasis Vulgaris , 2004, The Journal of experimental medicine.

[24]  C. Griffiths,et al.  Oral liarozole in the treatment of palmoplantar pustular psoriasis: a randomized, double‐blind, placebo‐controlled study , 2001, The British journal of dermatology.

[25]  A. Finlay,et al.  Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use , 1994, Clinical and experimental dermatology.